Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • NewsPress Releases

BOTOX® Cosmetic Advances Its Commitment to Entrepreneurial Empowerment with “The Confidence Project”

  • The Pharma Data
  • May 2, 2025

BOTOX® Cosmetic Expands Commitment to Female Empowerment with The Confidence Project for Women Entrepreneurs In a bold move to champion female entrepreneurship and narrow the persistent confidence gap between men…

Read MoreBOTOX® Cosmetic Advances Its Commitment to Entrepreneurial Empowerment with “The Confidence Project”
  • News

Eli Lilly Unveils Q1 2025 Financial Results, Showcases Strong Pipeline Progress

  • The Pharma Data
  • May 2, 2025

Eli Lilly Reports Strong Q1 2025 Financial Results, Driven by Surging Demand for Mounjaro and Zepbound, While Advancing Pipeline Innovations Eli Lilly and Company (NYSE: LLY) has delivered a robust…

Read MoreEli Lilly Unveils Q1 2025 Financial Results, Showcases Strong Pipeline Progress
Vaccine
  • Research

Vaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery

  • The Pharma Data
  • May 2, 2025

Vaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery PharmaJet®, a company committed to advancing the performance, safety, and effectiveness of injectable vaccines and therapies through innovative needle-free injection…

Read MoreVaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery
HSS
  • Research

AI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement

  • The Pharma Data
  • May 2, 2025

AI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement At the 50th Annual Meeting of the American Society of Regional Anesthesia and Pain Medicine (ASRA), a groundbreaking…

Read MoreAI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement
AndHealth
  • Press Releases

PrimaryOne Health and AndHealth Cut Ribbon on New Retail & Specialty Pharmacy to Enhance Community Medication Access

  • The Pharma Data
  • May 2, 2025

PrimaryOne Health and AndHealth Cut Ribbon on New Retail & Specialty Pharmacy to Enhance Community Medication Access PrimaryOne Health, in partnership with AndHealth, proudly celebrated the grand opening of its…

Read MorePrimaryOne Health and AndHealth Cut Ribbon on New Retail & Specialty Pharmacy to Enhance Community Medication Access
Tirzepatide
  • Research

New SURPASS-3 Data Links Tirzepatide to Muscle Composition Changes in Type 2 Diabetes

  • The Pharma Data
  • May 2, 2025

New SURPASS-3 Data Links Tirzepatide to Muscle Composition Changes in Type 2 Diabetes In an increasingly dynamic and rapidly evolving field of metabolic disease management, the nuanced effects of weight…

Read MoreNew SURPASS-3 Data Links Tirzepatide to Muscle Composition Changes in Type 2 Diabetes
Bio-Rad
  • BusinessPress Releases

Bio-Rad Announces Financial Results for the First Quarter of 2025

  • The Pharma Data
  • May 2, 2025

Bio-Rad Announces Financial Results for the First Quarter of 2025 Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics, released its financial results for the…

Read MoreBio-Rad Announces Financial Results for the First Quarter of 2025
Crown Bioscience
  • News

Crown Bioscience and NEXT Oncology Expand Strategic Partnership

  • The Pharma Data
  • May 2, 2025

Crown Bioscience and NEXT Oncology Expand Strategic Partnership In a significant development that reinforces their shared vision for transforming cancer research and drug development, Crown Bioscience, a global contract research…

Read MoreCrown Bioscience and NEXT Oncology Expand Strategic Partnership
Genmab
  • Regulatory

Genmab to Submit sBLA to FDA for Epcoritamab Combo in Relapsed/Refractory Follicular Lymphoma

  • The Pharma Data
  • May 2, 2025

Genmab to Submit sBLA to FDA for Epcoritamab Combo in Relapsed/Refractory Follicular Lymphoma Genmab A/S, a leading international biotechnology company specializing in the development of antibody therapeutics for the treatment…

Read MoreGenmab to Submit sBLA to FDA for Epcoritamab Combo in Relapsed/Refractory Follicular Lymphoma
, PCI Pharma
  • NewsBusiness

PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity

  • The Pharma Data
  • May 2, 2025

PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity PCI Pharma Services, a globally recognized contract development and manufacturing organization (CDMO) specializing in…

Read MorePCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity
Sapient
  • Press Releases

Sapient Unveils DynamiQ Next-Gen Data Insights Engine for Drug Discovery and Development

  • The Pharma Data
  • May 1, 2025

Sapient Unveils DynamiQ Next-Gen Data Insights Engine for Drug Discovery and Development Sapient, a pioneering leader in multi-omics data generation and clinical insights, has unveiled its next-generation multi-omics and real-world…

Read MoreSapient Unveils DynamiQ Next-Gen Data Insights Engine for Drug Discovery and Development
Biosciences
  • Research

Predicta Biosciences Unveils First Molecular Diagnostic for Enhancing Multiple Myeloma Prognosis

  • The Pharma Data
  • May 1, 2025

Predicta Biosciences Unveils First Molecular Diagnostic for Enhancing Multiple Myeloma Prognosis Predicta Biosciences, a precision oncology company, has officially launched its first Laboratory Developed Test (LDT), GenoPredicta, a cutting-edge diagnostic…

Read MorePredicta Biosciences Unveils First Molecular Diagnostic for Enhancing Multiple Myeloma Prognosis
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • WuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Facility as Key Equipment Arrives
  • Johnson & Johnson Initiates Landmark Head-to-Head Trial of Pulsed Field Ablation in Persistent Atrial Fibrillation
  • Dental Care Alliance Unveils Strategic Deal to Reinforce Financial Position and Drive Long-Term Growth
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.